ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
1.420
+0.050 (3.65%)
At close: Dec 5, 2025, 4:00 PM EST
1.430
+0.010 (0.70%)
After-hours: Dec 5, 2025, 7:49 PM EST
ALX Oncology Holdings Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 77 | 88 | 742 | 459 | 870 | 3,435 | |
| Market Cap Growth | 19.65% | -88.13% | 61.50% | -47.23% | -74.66% | - | |
| Enterprise Value | 32 | -43 | 567 | 181 | 488 | 3,181 | |
| Last Close Price | 1.42 | 1.67 | 14.89 | 11.27 | 21.49 | 86.20 | |
| PS Ratio | - | - | - | - | - | 2905.75 | |
| PB Ratio | 1.70 | 0.78 | 3.91 | 1.74 | 2.40 | 7.99 | |
| P/TBV Ratio | 1.72 | 0.78 | 3.91 | 1.74 | 2.40 | 7.99 | |
| EV/Sales Ratio | - | - | - | - | - | 2691.10 | |
| Debt / Equity Ratio | 0.35 | 0.15 | 0.05 | 0.04 | 0.00 | - | |
| Asset Turnover | - | - | - | - | - | 0.01 | |
| Quick Ratio | 2.20 | 6.95 | 5.10 | 9.40 | 23.78 | 69.99 | |
| Current Ratio | 2.40 | 7.26 | 5.24 | 9.57 | 24.00 | 70.28 | |
| Return on Equity (ROE) | -118.95% | -88.91% | -70.97% | -39.42% | -21.05% | -21.30% | |
| Return on Assets (ROA) | -50.50% | -45.62% | -38.77% | -23.20% | -12.80% | -12.22% | |
| Return on Capital (ROIC) | -63.17% | -53.97% | -45.07% | -25.02% | -13.16% | -12.55% | |
| Return on Capital Employed (ROCE) | -197.20% | -110.20% | -82.40% | -45.80% | -22.90% | -10.20% | |
| Earnings Yield | -140.29% | -153.10% | -21.68% | -26.88% | -9.59% | -1.33% | |
| FCF Yield | -126.55% | -138.92% | -17.75% | -19.74% | -7.90% | -1.12% | |
| Buyback Yield / Dilution | -5.27% | -21.37% | -5.62% | -0.97% | -118.05% | -500.86% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.